Breaking News, Collaborations & Alliances

PeptiDream Expands Peptide Discovery Collaboration with Novartis

Will use its Peptide Discovery Platform System technology to identify and optimize novel macrocyclic peptides against targets selected by Novartis.

Author Image

By: Charlie Sternberg

Associate Editor

PeptiDream Inc., a Japan-based biopharmaceutical company, is expanding its peptide discovery collaboration with Swiss-based Novartis Pharma AG.   Under the multi-program agreement, PeptiDream will use its proprietary Peptide Discovery Platform System (PDPS) technology to identify and optimize novel macrocyclic peptides against targets selected by Novartis, for potential conjugation to radionuclides or other applications for both therapeutic and diagnostic purposes.   This new agreement expan...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters